PCAOB and Beijing reach audit agreement to prevent mass delisting; U.S.-China merger abandoned following U.S. antitrust investigation; new compliance rules for wealth management companies
August 29, 2022
Mergers and Acquisitions
A U.S. company acquiring a Chinese company will face a multitude of regulatory restrictions and requirements. How can the U.S. acquirer manage the risk of the deal being blocked or unwound for non-compliance?
August 18, 2022SAMR proposes to raise the thresholds for concentration filings
July 22, 2022Revised Anti-monopoly Law includes provisions on hub and spoke conspiracies
July 22, 2022Nate Bush, Ray Xu and Della Ding of DLA Piper highlight key changes to merger control under the Amended Anti-Monopoly Law and draft regulations including increased revenue thresholds, investigation of "below threshold" transactions and clarification of what is meant by gun-jumping
July 22, 2022SAMR issues 28 administrative penalties for failing to disclose M&A deals; CAC clarifies details about data export security assessment; banks and insurance companies to support advanced manufacturing
July 12, 2022Law firms shall strengthen their management of insider information
June 24, 2022Anti-monopoly guidelines are set forth regarding the active pharmaceutical ingredient sector
June 17, 2022Kainan Zhang and Junting Lei of Haiwen & Partners highlight the main PRC foreign exchange regulatory requirements of different types of cross-border investment and trade by domestic and foreign individuals and institutions under capital and current accounts.
April 11, 20222021 regulatory trends in China, including antitrust, data privacy, sanctions, healthcare, PE/VC, capital markets, IP, banking & finance, TMT and arbitration.
February 09, 2022
